<DOC>
	<DOCNO>NCT00554840</DOCNO>
	<brief_summary>The purpose propose pilot study examine use varenicline people schizophrenia specifically assess tolerability efficacy smoke cessation . Specifically , The primary objective pilot study determine take varenicline along individual smoking cessation supportive program safe effective treatment nicotine addiction schizophrenic patient . We hypothesize varenicline treat patient achieve high rate smoke cessation receive placebo individual support .</brief_summary>
	<brief_title>Comparison Varenicline Placebo Smoking Cessation Schizophrenia</brief_title>
	<detailed_description>The primary objective data analysis measure rate smoke cessation two treatment group . Smoking cessation measure weekly composite measure self-reported abstinence , end expire carbon monoxide ( CO ) less C10 ppm urine cotinine dipstick measure &lt; 30 ng/ml . The primary endpoint point prevalence 12 week . The four week continuous abstinence rate last four week treatment phase also evaluate . The point prevalence abstinence rate also obtain . The secondary objective determine whether smoke cessation associate worsen cognition psychiatric symptomology . We hypothesize subject achieve abstinence varenicline group show worsen neurocognitive symptom measure compare abstinence subject placebo group . Lastly , attempt identify clinical topographic marker predict cessation .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Age 1864 Regular ten cigarette per day smoker one year Nicotine Dependency Score great equal four DSMIV Diagnosis Schizophrenia Schizoaffective disorder Psychiatric medication regimen unchanged least 90 day Psychiatric medication dosage unchanged least 30 day Psychiatric hospitalization last 6 month Meets criteria current Major Depressive Disorder score great 10 Calgary Depression Scale ( see withdrawal criterion ) Suicide homicide ideation plan last six month Life time history suicide attempt Has diagnosis Schizophrenia Schizoaffective disorder less three year Current treatment Bupropion SR DSMIV diagnosis alcohol substance dependence within last 6 months* DSMIV diagnosis alcohol substance abuse within three month * Pregnancy lactation female ( +HCG ) Use tobacco product cigarette Use nicotine replacement Unstable serious medical condition last 6 month Regular use cimetidine ( OTC Rx ) *Substance abuse/dependency exclusion apply abuse dependence nicotine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>